Shots:
- The US FDA has approved Bravecto Quantum (Fluralaner for Extended-Release Injectable Suspension), a once-yearly injectable for flea and tick protection in dogs, will be available in U.S. veterinary clinics by Aug, 2025
- Bravecto Quantum kills adult fleas and controls flea and tick infestations (Ixodes scapularis, Dermacentor variabilis, Rhipicephalus sanguineus) for 12 mos., and Amblyomma americanum for 8 mos., in dogs and puppies 6 mos. and older
- Bravecto Quantum was approved in Australia & New Zealand in 2023, then the EU in 2024, and authorized in over 50 countries worldwide
Ref: Merck | Image: Merck Animal Health | Press Release
Related News:- Merck Animal Health Reports the CVMP Positive Opinion for Nobivac L6 and Nobivac LoVo L6 Vaccines for Canine Leptospirosis
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
